Intercell AG
36Patents
21Active
36Granted
45Portfolio score
Filing activity: Jan 27, 1999 → Aug 3, 2012 · 16 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6869607B1 | Vaccine formulations | Human Necessities | 54 | Expired |
| US7148191B2 | Antigenic composition | Chemistry; Metallurgy | 38 | Expired |
| US7438912B2 | S.agalactiae antigens I + II | Chemistry; Metallurgy | 30 | Expired |
| US7485710B2 | Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof | Human Necessities | 27 | Expired |
| US8372411B2 | S. pneumoniae antigens | Chemistry; Metallurgy | 18 | Active |
| US7635487B2 | S. pneumoniae antigens | Chemistry; Metallurgy | 17 | Expired |
| US7704514B2 | Vaccines | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7378234B2 | Method for isolating hepatitis C virus peptides | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7244438B2 | Uses for polycationic compounds | Human Necessities | 7 | Expired |
| US7638136B2 | Streptococcus pyogene antigens | Chemistry; Metallurgy | 7 | Expired |
| US7771728B2 | Method for identification, isolation and production of antigens to a specific pathogen | Emerging Cross-Sectional Technologies | 7 | Active |
| US8129165B2 | Borrelia antigens | Emerging Cross-Sectional Technologies | 5 | Active |
| US8323660B2 | Method for identification, isolation and production of antigens to a specific pathogen | Emerging Cross-Sectional Technologies | 5 | Active |
| US7968297B2 | Method for identification, isolation and production of antigens to a specific pathogen | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7927607B2 | S. agalactiae antigens I and II | Chemistry; Metallurgy | 4 | Active |
| US8449892B2 | S. agalactiae antigens I and II | Chemistry; Metallurgy | 4 | Active |
| US7528223B2 | Antigens encoded by alternative reading frames from pathogenic viruses | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8277815B2 | Pharmaceutical composition comprising an antigen | Chemistry; Metallurgy | 3 | Active |
| US8303961B2 | Borrelia antigens | Human Necessities | 3 | Active |
| US7960533B2 | Nucleic acids coding for adhesion factor of group B Streptococcus, adhesion factors of group B Streptococcus and further uses thereof | Human Necessities | 3 | Active |
| US8361476B2 | Vaccine composition comprising an antigen and a peptide having adjuvant properties | Emerging Cross-Sectional Technologies | 2 | Active |
| US7658928B2 | Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide | Human Necessities | 2 | Active |
| US8236326B2 | Klebsiella antigens | Chemistry; Metallurgy | 1 | Active |
| US7628994B2 | S. epidermidis antigens | Human Necessities | 1 | Expired |
| US8318908B2 | Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.